1-3 of 3
Keith L. Dawson, DNP, RN
Close
Sort by
Journal Articles

PET Compared With CT As a Prognosticator After Rituximab Induction Therapy In Follicular Lymphoma: Report From The National Lymphocare Study

Ida Wong-Sefidan, MD, Michelle Byrtek, PhD, Xiaolei Zhou, MS, Jonathan W. Friedberg, MD, Christopher Flowers, MD, Brian K Link, MD, Andrew D. Zelenetz, MD, PhD, Keith L Dawson, DNP, RN, Erin G. Reid, MD, MS
Journal: Blood
Blood (2013) 122 (21): 4245.
https://doi.org/10.1182/blood.V122.21.4245.4245
Published: 2013
Journal Articles

A Proposed Prognostic Model For Overall Survival In The Oldest Old (>80 Years Old) Follicular Lymphoma Patients

Chadi Nabhan, MD, FACP, Michelle Byrtek, PhD, Keith L Dawson, DNP, RN, Xiaolei Zhou, MS, Brian K Link, MD, Jonathan W. Friedberg, MD, Andrew D. Zelenetz, MD, PhD, James R Cerhan, MD, PhD, Christopher R. Flowers, MD, MS
Journal: Blood
Blood (2013) 122 (21): 3058.
https://doi.org/10.1182/blood.V122.21.3058.3058
Published: 2013
Journal Articles

Early Relapse Of Follicular Lymphoma After R-CHOP Uniquely Defines Patients At High Risk For Death: An Analysis From The National Lymphocare Study

Carla Casulo, MD, Michelle Byrtek, PhD, Keith L. Dawson, DNP, RN, Xiaolei Zhou, MS, Charles Farber, MD, Christopher R. Flowers, MD, MS, John D. Hainsworth, MD, Brian K Link, MD, Andrew D. Zelenetz, MD, PhD, Jonathan W. Friedberg, MD
Journal: Blood
Blood (2013) 122 (21): 510.
https://doi.org/10.1182/blood.V122.21.510.510
Published: 2013